West Virginia University Logo

April 23, 2014


SAMHSA Prescription Drug Abuse Weekly Update
Issue 68  |  April 23, 2014
The Prevention of Prescription Drug Abuse in the Workplace (PAW) TA Center addresses prescription drug abuse—a growing public health problem with increasing burdens on workers, workplaces, and our economy. To subscribe colleagues, family members, or friends to this listserv sponsored by the Substance Abuse and Mental Health Services Administration (SAMHSA), please click here or send their e-mail addresses to paw@dsgonline.com.
Table of Content Featured Article Journal Articles and Reports Professional News Other State and Local News Other Resources Video Webinar Grant Announcements Take-Back Events and Drop Boxes Save the Dates Upcoming Conferences and Workshops


Team Awareness: Resilience Facilitator Training
Organizational Wellness and Learning Systems
May 5–8, 2014
8:30 a.m. to 5:30 p.m.
Madison Park Church of God
6607 Providence Drive
Anderson, Indiana

Team Awareness and Team Resilience curricula have been used by many types of workplaces. Their modules include Relevance and Well-Being, Policy and Accountability, Raw Coping Power, Tolerance and Destigmatization, Communication, and Encouragement and Compassion (Nudging). A new module covering prescription drug use will be released at this training. Randomized clinical trials of the full curriculum (absent the new module) show improved skills in stress management, reduced stigma, increased help-seeking, improved work climate, and reductions in problem drinking. This training provides a full review of the entire curriculum so facilitators can replicate the program with fidelity to the original scientific protocol. The 4½-day course uses an 1) Observe, 2) Debrief, and 3) Practice Protocol for each module. Participants will prepare and deliver modules to receive peer feedback. Participants receive access to the PowerPoint slide deck, facilitator notes, handouts, ideas for customization, and session rating forms.

Read more:

Department of Veterans Affairs. 2014. "Disclosures to Participate in State Prescription Drug Monitoring Programs. Final Rule." Federal Register 79(50):14400–14401.

The Department of Veterans Affairs finalized regulations that allow it to participate in state prescription drug monitoring programs.

Read more:

Journal Articles and Reports

Sudie E. Back, Daniel F. Gros, Jenna L. McCauley, Julianne Flanagan, Elizabeth Cox, Kelly Barth, and Kathleen T. Brady. 2014. "Laboratory-Induced Cue Reactivity Among Individuals With Prescription Opioid Dependence." Addictive Behaviors, doi:10.1016/j.addbeh.2014.04.007

Drug cue reactivity paradigms examine risk factors for relapse. This study developed and evaluated possible components of a prescription opioid cue paradigm. The study included 20 opioid-dependent participants and 17 controls. The cues included an induction script, viewing and handling paraphernalia (e.g., a bottle of Oxycontin pills, a pill crusher) and watching a video depicting people using prescription opioids and places related to prescription opioids (e.g., pharmacies). Prescription opioid abusers but not controls reported significant pre-cue to post-cue increases on subjective ratings of craving, difficulty resisting prescription opioid, stress, and anger, as well as increases in heart rate and salivary cortisol levels. Both groups evidenced significant pre-cue to post-cue increases in physiological responses (e.g., blood pressure, skin conductance), which suggests these cues are not useful indicators.

Read more:

Andréa Dâmaso Bertoldi, Aline Lins Camargo, Marysabel Pinto Telis Silveira, Ana M.B. Menezes, Maria Cecília Formoso Assunção, Helen Gonçalves, and Pedro Curi Hallal. 2014. "Self-Medication Among Adolescents Aged 18 Years: The 1993 Pelotas (Brazil) Birth Cohort Study." Journal of Adolescent Health, doi:10.1016/j.jadohealth.2014.02.010

Using Pelotas (Brazil) Birth Cohort Study data from 2011, analysts estimated the prevalence of self-medication among 4,106 adolescents at age 18, the types of drugs used (over the counter versus prescription), and socioeconomic, health-related, and behavioral correlates of self-medication. Among respondents, 41.1 percent reported using medicines (95 percent CI 39.6–42.6), with 65.1 percent of medicine users self-medicating (95 percent CI 62.8–67.4). Of drugs used for self-medication, 78.7 percent were nonprescription drugs and 21.3 percent were misused prescription drugs.

Read more:

Katie Jane Blum, Andrew Gonzales, Kelly Kyrouac, and Sora Lyu. "Effect of Generation Rx Programming on Knowledge and Attitudes Surrounding Prescription Drug Misuse Among Butler Students." Paper presented at Butler University, Undergraduate Research Conference, April 11, 2014, Indianapolis, Ind.

This narrow student project used a pretest–posttest design to assess the effectiveness of Generation Rx presentations at educating students and changing their attitudes toward prescription drug misuse. Presentations were given during meetings of two student organizations and one elective course on Butler's campus. Although 54 presurveys and 62 postsurveys were completed, only 39 pairs were matched. Among those, 10.3 percent reported misusing a prescription drug within the past year. Before the presentation, 51.3 percent of respondents disagreed or strongly disagreed that prescription drugs were safer to abuse than illicit drugs, compared with 97.4 percent after the presentation. The percentage of students who stated they were "likely" or "very likely" not to misuse prescription drugs increased from 76.9 percent to 92.3 percent.

Read more:

Rishi J. Desai, Sonia Hernandez–Diaz, Brian T. Bateman, and Krista F. Huybrechts. 2014. "Increase in Prescription Opioid Use During Pregnancy Among Medicaid-Enrolled Women." Obstetrics and Gynecology, doi:10.1097/AOG.0000000000000208.

Researchers used Medicaid data from 2000 through 2007 to analyze prevalence of prescription opioid use and usage trend during pregnancy. Claims analyzed came from 1.1 million women spread across 46 U.S. states and Washington, D.C. One of five women (21.6 percent) filled a prescription for an opioid during pregnancy; this proportion increased from 18.5 percent in 2000 to 22.8 percent in 2007. Usage ranged between 9.5 percent and 41.6 percent across states. Codeine and hydrocodone were the most commonly prescribed opioids. Among women filling at least one opioid prescription, the median number of prescriptions filled was 1 and the median cumulative days of opioid availability during pregnancy was 5 (with an interquartile range of 3–13).

Read more:

J. Elander, J. Duarte, F.A. Maratos, and P. Gilbert. 2014. "Predictors of Painkiller Dependence Among People With Pain in the General Population." Pain Medicine 15(4):613–24, doi: 10.1111/pme.12263.

An online survey of a snowball sample seeded with emails to employees of a university and a large hospital in Portugal drew responses from 112 people who had pain and used pain relievers in the last month. In multiple regression, the independent predictors of pain reliever dependence were prescription pain reliever use (β 0.21), Screener and Opioid Assessment for Patients With Pain score (β 0.31), and pain acceptance (β –0.29). Prescription pain reliever use mediated the influence of pain intensity. Alexithymia (difficulty in identifying and describing one's own emotions), anxiety, and pain acceptance all moderated the influence of pain. People at greatest risk of developing pain reliever dependence use prescription pain relievers more frequently, have a prior history of substance-related problems more generally, and are less accepting of pain. Based on these findings, the article posits a preliminary model with three types of influence on development of pain reliever dependence: 1) pain leading to pain reliever use, 2) risk factors for substance-related problems irrespective of pain, and 3) psychological factors related to pain.

Read more:

Related Commentary

Martin D. Cheatle. 2014. "Psychological Dependence and Prescription Opioid Misuse and Abuse." Pain Medicine 15(4):541–43, doi: 10.1111/pme.12419

Among the possible indicators tested in the Elander study, the Screener and Opioid Assessment for Patients With Pain (the only standardized assessment tool used in the study) was the best predictor of analgesic dependence. The research also identified frequency of analgesic use and level of acceptance of pain as predictors.

Read more:
A.D. Furlan, P. Macdougall, D. Pellerin, K. Shaw, D. Spitzig, G. Wilson, and J. Wright. 2014. "Overview of Four Prescription Monitoring/Review Programs in Canada." Pain Research and Management 19(2):102–06.

Managers of prescription drug monitoring programs in Alberta, British Columbia, Nova Scotia, and Saskatchewan described their programs. All four programs are at least six years old and permit pharmacist access. Physicians need patient consent to access the British Columbia data. Three programs include a mix of review and monitoring; British Columbia restricts itself to review and education. All programs include controlled substances. Anabolic steroids are included in Nova Scotia and Saskatchewan; cannabinoids are included in British Columbia and Nova Scotia. Double doctoring, double pharmacy and high-volume dispensing are considered to be red flags in all programs.

Read more:

S. Kaley, M.J. Mancino, and E. Messias. 2014. "Sadness, Suicide, and Drug Misuse in Arkansas: Results From the Youth Risk Behavior Survey 2011." Journal of the Arkansas Medical Society 110(9):185–86.

In the 2011 Arkansas Youth Risk Behavior Survey, 13.2 percent of high school students reported they had used prescription drugs without a prescription. Suicidality was more strongly associated with prescription drug abuse than inhalant or cannabis abuse.

Read more:

Ding–Lieh Liao, Cheng–Yi Huang, Sien Hu, Su–Chen Fang, Chi–Shin Wu, Wei–Ti Chen, Tony Szu–Hsien Lee, Pau–Chung Chen, and Chiang–Shan R. Li. 2014. "Cognitive Control in Opioid Dependence and Methadone Maintenance Treatment." PLoS ONE 9(4):e94589. doi:10.1371/journal.pone.0094589

Researchers experimentally tested for cognitive control deficits in individuals with opioid dependence. They used a reaction time test with two trial types: "go" and "stop," randomized in presentation. A small dot appeared on the computer screen to engage attention at the beginning of a trial. After a randomized time interval between 1 and 2 seconds, the dot turned into a circle, instructing subjects to quickly press a mouse button. The circle vanished at button press or after one second had elapsed—whichever came first—and the trial terminated. Approximately two thirds of all trials were go trials. The remaining were stop trials. These trials followed the same sequence except that the go signal was followed by a stop signal, instructing subjects to withhold button press. The time interval between the stop and go signals—the stop-signal delay—started at 200 ms and varied from one stop trial to the next according to a staircase procedure, increasing and decreasing by 64 ms each following a stop success and error trial. Subjects were instructed to respond to the go signal quickly while keeping in mind that a stop signal could come up occasionally. Two-hundred-and-sixty-four men with opioid dependence who were incarcerated at a detention center and abstinent for up to two months (n=108) or at a correctional facility and abstinent for approximately six months (n=156), 65 opioid-dependent men under methadone maintenance treatment at a psychiatric clinic, and 64 age- and education-matched healthy control participants were assessed. Stop signal reaction time was significantly prolonged in opioid dependence but not methadone maintenance treatment individuals, compared with healthy controls. Post-error slowing diminished in opioid dependence and methadone maintenance treatment compared with healthy controls (trend; p=0.061), with no difference between the opioid dependence and methadone maintenance treatment groups. Individuals in longer abstinence were no less impaired in these measures. Moreover, these results remained when psychiatric comorbidities including misuse of other substances were accounted for.

Read more:

M. Papakosta, D. Zavras, and D. Niakas. 2014. "Investigating Factors of Self-Care Orientation and Self-Medication Use in a Greek Rural Area." Rural and Remote Health 14:2349.

Researchers examined self-care orientation and use of prescription medications without a doctor's prescription in a Greek rural area. They started from 150 randomly conducted face-to-face interviews in early 2011. Most respondents (80 percent) were self-care oriented, and 54.7 percent had used prescription medications without a prescription. Factors that increased self-care orientation and self-medication were female gender (OR 3.44, 95 percent CI 1.37–8.66), absence of chronic disease (OR 0.30, 95 percent CI 0.098–0.92), and higher educational level (OR 1.64, 95 percent CI 1.05–2.58). Individuals who practiced self-medication with prescription drugs were self-care oriented (OR 6.16, 95 percent CI 2.38–15.89) and had lower self-rated health status (OR 0.65, 95 percent CI 0.42–0.99).

Read more:

Professional Education News & Editorial

Silvia N. Calderon and Michael Klein. 2014. "A Regulatory Perspective on the Abuse Potential Evaluation of Novel Stimulant Drugs in the United States." Neuropharmacology, doi:10.1016/j.neuropharm.2014.04.001

This article describes the regulatory framework for evaluating abuse potential of new drugs, in general, including novel stimulants. It also discusses the U.S. Food and Drug Administration's roles in evaluating abuse potential of drugs and in drug control. The paper offers a definition of abuse potential, an overview of currently accepted approaches to evaluating the abuse potential of a drug, and a description of the criteria used in recommending a specific level of control (i.e., a schedule) for a drug under the Controlled Substances Act.

Read more:

Rosemary Frei. 2014. "Pain Physicians Push for Abuse-Deterrent Formulation of Morphine." Pain Medicine 12(4).

The authors believe development and approval of an abuse-deterrent formulation of extended-release morphine should be fast-tracked. Morphine is widely available, frequently prescribed, and inexpensive with no abuse-deterrent formulation product marketed in the United States. In January 2013, Food and Drug Administration officials produced an opioid abuse–deterrent formulation development guidance for industry that considers development of these products a high public health priority. As more abuse-deterrent formulations reach the market, migration to drugs that still lack abuse deterrents will increase.

Read more:

Karran A. Phillips, David H. Epstein, and Kenzie L. Preston. 2014. "Psychostimulant Addiction Treatment." Neuropharmacology, doi:10.1016/j.neuropharm.2014.04.002

Stimulant-use disorders remain prevalent and can result in both short-term and long-term adverse consequences. No form of agonist maintenance for psychostimulants has regulatory approval or is generally accepted for use, although some promising candidates exist. Currently the mainstay of treatment remains behavioral interventions.

Read more:


U.S. Court Reverses Massachusetts Ban on Zogenix Pain Drug
April 15, 2014

A U.S. District Court judge stopped Massachusetts from implementing a ban on the sale of Zohydro, saying federal law superseded the state's action. Massachusetts Gov. Patrick had announced a ban on the drug, formally declaring a public health emergency on March 27. The U.S. District Court for Massachusetts granted a preliminary injunction against the ban, saying that by imposing its own conclusion about the safety and efficacy of Zohydro the state was obstructing the Food and Drug Administration's constitutionally mandated charge.

Read more:

New Prescription Painkiller May Be Bound for Canada
Toronto Sun
April 13, 2014

The president of Paladin Labs Incorporated told the Toronto Sun the firm will apply to market Zohydro ER in Canada. He did not say when the application for the prescription pain reliever will be filed with Health Canada. David Juurlink, head of clinical pharmacology and toxicology at Sunnybrook hospital, said there is no need for Zohydro ER in Canada and it will exacerbate the country's already-serious opioid addiction problem.

Read more:

Drug Firms Have Used Dangerous Tactics to Drive Sales to Treat Kids
Denver (Colo.) Post
April 14, 2014

This article discusses how pharmaceutical companies provided incentives to doctors to prescribe psychotropic drugs to children, particularly those in foster care in Colorado. The article also highlights some cases against pharmaceutical companies that have agreed to pay more than $13 billion to resolve U.S. Department of Justice allegations of fraudulent marketing practices. A Denver Post investigation into antipsychotic use found that, in 2012 in Colorado, foster children were prescribed the potent mood-altering drugs at a rate 12 times as high as other children on Medicaid. Dosages and rates of multidrug prescriptions also were high among foster children. Colorado officials knew about rising prescription rates and dosages of psychotropic drugs as early as 2007 but did not convene a panel to address the issue for more than five years. Court documents show that drug companies closely tracked the prescribing habits of doctors in the Medicaid program. In Colorado, 9 of the 10 most prescribed drugs for foster children on Medicaid are psychotropics. In contrast, for nonfoster children, only 1 psychotropic is among the top 10 most prescribed drugs in Medicaid. A Rutgers University study found that at least three fourths of all children prescribed antipsychotics through Medicaid took them for off-label uses not approved by the Food and Drug Administration.

Read more:

Minister Ambrose Continues to Fight Prescription Drug Abuse
Canadian Newswire
April 15, 2014

The Canadian Minister of Health reaffirmed her commitment to address prescription drug abuse. She will review recommendations from a report titled The Government's Role in Addressing Prescription Drug Abuse in Canada. The Government has committed to expanding the scope of its national antidrug strategy to address prescription drug abuse. These actions build on steps already taken to limit illegal diversion of prescription opioids through tighter licensing rules. Through the Non-Insured Health Benefits Prescription Monitoring Program, the government is also addressing potential misuses of prescription drugs so that First Nations and Inuit clients can get the medications they need without being put at risk.

Read more:

Just Say Yes? The Rise of 'Study Drugs' in College
April 17, 2014

Some college students take attention deficit hyperactivity disorder medications such as Adderall and Ritalin to help them concentrate. The prescription drugs are becoming increasingly popular among college students who have not been diagnosed with ADHD. The vast majority of college students do not perceive risks associated with taking the "study drugs." Experts caution that students may not know proper dosage or think about drug interactions that can have side effects and other health consequences such as headaches and difficulty sleeping.

Read more:

Workplace Drug Testing Tipped to Increase, Despite Misgivings
Sydney (Australia) Morning News
April 14, 2014

This article discusses the growing trend of workplace drug testing in Australia. Experts say it is likely to become increasingly common as employers attempt to cut "presenteeism" and ensure safety. Unions say the tests are an unfair invasion of privacy, particularly when they come in the form of a urine test. The Global Drug Survey, a survey of nearly 5,850 Australian drug and alcohol users, found that one person in every eight had been asked by his or her employer to take a drug test. More than one third of fulltime workers surveyed said they had taken drugs or alcohol within two hours of starting work, and some had even begun to use psychoactive drugs in an attempt to stay one step ahead of the testers. Ken Pidd, the deputy director, research, at the National Center for Education and Training on Addiction, recently conducted a review of the evidence in favor of the tests and found that, outside of a few circumstances, there was little proof they improved safety. Pidd said studies had found the overall rate of use of drugs and alcohol in the workplace in Australia was relatively low. He admits that prescription drug abuse is increasing generally, so it is likely to be increasing in the workplace as well. He said prescription drugs posed a particular problem for people returning to work from injury, as they could exacerbate problems by doing more damage with dulled pain sensations.

Read more:

Opioids Are Among the Most-Prescribed Drugs; Here Are Some Common Versions
Washington Post
April 14, 2014

This article briefly discusses the most commonly prescribed drugs in the country. Powerful opioids that are abused, misused, and cause overdose deaths include hydrocodone, oxycodone, morphine, and Naproxen.

Read more:

Heroin a Growing Threat Across United States, Say Nation's Police
USA Today
April 17, 2014

Law enforcement officials from across the country met recently for the Police Executive Research Forum's National Summit. They said heroin and other opiate addiction is now claiming more lives in many communities than violent crime and car crashes. The yet-to-be released National Drug Threat Assessment rated heroin as the second-greatest drug risk, after methamphetamine. U.S. Atty. Gen. Eric Holder cited the rising number of overdose deaths from heroin and other dangerous opioids, and he restated the need for police to carry naloxone when responding to overdose calls.

Read more:

Google Faces New Pressure From States to Crack Down on Illegal Online Drug Sales
Washington Post
April 15, 2014

State attorneys general want Google to make it harder for its users to find counterfeit prescription medicine and illegal drugs online. They sent their complaints in a letter signed by 24 top state prosecutors. Google executives held private meetings to address their concerns. Google noted at the meeting that it is increasing spending on policy enforcement by 10 percent this year, to $114.5 million. Google said it was hiring 120 people this year to flag rogue ads and videos. It also said it was eliminating 1,200 predicted search/auto-complete phrases that led people to potentially illegal or dangerous Web sites. Mississippi Atty. Gen. Jim Hood has threatened to pursue legal action if Google does not go further by removing from its search results sites that sell illicit drugs and other illegal products.

Read more:

Other State and Local News

Prescription Drug Abuse Increases on U.S. Campuses
Arkansas Traveler
April 16, 2014

This article gives an overview of prescription drug abuse among college students nationwide and at the University of Arkansas specifically. Adderall and Oxycontin are the most popular medications at the University of Arkansas. The article explains that prescription pain relievers can pose serious health risks.

Read more:

Ballot Initiative Seeks Drug Testing for Doctors
Bakersfield Californian
April 12, 2014

California voters are considering a proposed ballot initiative aimed at medical malpractice and abuse. The initiative, known as the Troy and Alana Pack Patient Safety Act, would 1) mandate drug testing for doctors to prevent physician substance abuse, 2) require physicians to use the prescription drug monitoring program to catch drug addicts consulting multiple doctors, and 3) eliminate the state's 38-year-old malpractice cap. The California Medical Association opposes the ballot measure. County election offices are in the process of validating 842,947 signatures gathered to put the issue before voters on Nov. 4. It needs 504,760 valid signatures to qualify.

Read more:

Ohio House Goes After Addiction to Opiates
Columbus Dispatch
April 13, 2014

The Ohio House of Representatives passed four bills to increase funding for drug treatment and other measures aimed to address addictions. The House would fund addiction-treatment services across the state; ban physicians from prescribing drugs containing opiates without first reviewing a patient's prescription history through the prescription drug monitoring program; require written consent from a minor's parent or guardian before opiates are prescribed; and require hospice-care programs to establish procedures to prevent diversion of opiate drugs. Addiction treatment would be funded by reallocating most of the nearly $50 million recently provided to county boards of mental-health and addiction services. Under the plan, $25 million would be earmarked for housing for those addicted to pain relievers and other drugs.

Read more:

Bill Proposes Penalties for Certain 'Clean' Drug Tests
Bristol Bay Times
April 11, 2014

Proposed Alaska House Bill 370 would authorize employers to require drug testing of employees prescribed a controlled substance for over 90 days and to penalize 'clean' tests that indicate the medication may have been diverted. HB 370 also restricts narcotic prescriptions to a 30-day supply.

Read more:

As Sales of Painkillers Grow, So Do Overdose Deaths
Des Moines Register
April 13, 2014

This article and two videos (2 minutes 42 seconds and 2 minutes 33 seconds) discuss prescription drug abuse in Iowa and criminal cases against several medical professionals. Experts say pills are often wrongly prescribed and used inappropriately for long-term maladies. Regulators say physicians can avoid trouble by taking straightforward steps to ensure safety. Mark Bowden, executive director for the Iowa Board of Medicine, said his agency has put out clear guidelines on how to treat chronic pain, and it has even sent doctors free books on the subject. The board also now requires all primary-care doctors to receive at least two hours of instruction on pain care every five years.

Read more:

Prescription Pills Are Gaining Popularity With Eastern Idaho Kids
KPVI New 6
April 14, 2014

This article and video (2 minutes 4 seconds) discuss prescription drug abuse among high school students in Idaho. Local authorities warn parents to lock up their medications.

Read more:

Hard Drug Use on the Rise at University of Michigan
Michigan Daily
April 15, 2014

This article discusses the increase in drug use such as prescription stimulants and ecstasy among college students at the University of Michigan. University Police Chief Robert Neumann said he believes drug abuse on campus is a problem. The Institute for Research on Women and Gender and the Substance Abuse Research Center survey reports show that, since 2003, use of prescribed stimulants for nonmedical use has risen between 5.4 percent to 9.3 percent at the University.

Read more:

Oklahoma Addiction Specialist Offers Tips for Recovery
April 13, 2014

This article and video (2 minutes 40 seconds) condensed two recent interviews with Hal Vorse, a former pediatrician, who has dedicated the second half of his medical career to helping people wean themselves off highly addictive opiate pain relievers. Vorse urged Oklahoma officials and medical professionals to take more aggressive action to deal with the growing problem of prescription drug abuse.

Read more:

Prescription Drug Database: Help for Addicts or Invasion of Privacy?
April 16, 2014

This article discusses questions and answers about Pennsylvania's prescription drug monitoring program (PDMP). Pennsylvania doctors say the PDMP would help them recognize "doctor shoppers" and connect them with addiction treatment, and also identify people who are stockpiling prescription drugs to sell.

Read more:

Dropped Drug-Disposal Law Is Victory for Pharmaceutical Industry
SFGate.com (California)
April 16, 2014

California Senate Bill 1014 was dropped because legislators failed to get the required votes in the Senate Business, Professions, and Economic Development Committee. The bill would have required pharmaceutical companies to pay for a statewide drug take-back program.

Read more:

Other Resources

Treating for Two: Safer Medication Use in Pregnancy
Centers for Disease Control and Prevention
March 17, 2014

The Centers for Disease Control and Prevention started a Web site for its Treating for Two initiative, which offers clinicians and expecting patients up-to-date guidance on medication use in pregnancy. The site aims to prevent birth defects and to minimize exposures to potentially harmful medications during pregnancy.

Read more:


Former Inmate Describes Prescription Drug Use in Prison
April 14, 2014

A former federal inmate says she believes Canada's prisons are overmedicating inmates. She claims antipsychotic drugs are being prescribed as sleep aids. The Canadian Press and CBC launched a joint investigation into the allegations. [Duration: 1 minute 45 seconds.]


Drug Abuse Among Medical Professionals Rarely Detected
USA Today
April 15, 2014

This video (5 minutes 33 seconds) discusses prescription drug abuse among the health care community. Across the country, tens of thousands of doctors, nurses, medical technicians, and other health professionals struggle with abuse or addiction.

Read more:


The Value of Random Drug Testing: In the Prevalence of Prescription Drug Abuse
PreCheck, Incorporated
May 7, 2014
2:00 p.m. Eastern

This one-hour Webinar will cover best practices for implementing an employee random-drug-testing program and will review state laws. It will also discuss the extent of prescription drug abuse in the United States and how it may affect the workplace.

Read more:

Grant Announcements

Fiscal Year 2014 Harold Rogers Prescription Drug Monitoring Program
Bureau of Justice Assistance, U.S. Department of Justice
Deadline: May 6, 2014

Prescription Drug Overdose: Boost for State Prevention
Centers for Disease Control and Prevention
Deadline: June 4, 2014

Take-Back Events and Drop Boxes

Atlantic County (N.J.) Drug Collection Box Rakes in 54 Pounds of Pills in One Month
Galloway (N.J.) Patch
April 15, 2014

Medication Dropbox Installed at Quincy (Wash.) Police Station
iFiber One
April 14, 2014

New Prescription Drug Drop-Off Boxes in Champaign (Ohio) Villages
Springfield (Ohio) News–Sun
April 13, 2014

Sheriff's Office Installs Medicine Drop Box at Durham (N.C.) Courthouse
April 16, 2014

Save the Dates

National Take-Back Initiative
Drug Enforcement Administration
April 26, 2014

Sixth Annual American Medicine Chest Challenge National Day of Awareness and Safe Disposal of Prescription and Over-the-Counter Medicine
American Medicine Chest Challenge
November 8, 2014

Upcoming Conferences and Workshops

Prescription for Prevention: Preventing and Responding to Prescription Drug Abuse on Campus
Temple University, Villanova University, U.S. Attorney's Office, and the Clery Center
June 11, 2014
Philadelphia, Pennsylvania

Pharmacy Diversion Awareness Conference
U.S. Department of Justice, Drug Enforcement Administration
June 28–29, 2014—Renaissance Phoenix (Ariz.) Downtown
July 12–13, 2014—Sheraton Philadelphia (Pa.) Downtown Hotel
August 2–3, 2014—Denver (Colo.) Marriott Tech Center

Twenty-Seventh Annual NPN Prevention Research Conference
National Prevention Network
September 15–18, 2014

2014 Harold Rogers Prescription Drug Monitoring Program National Meeting
Brandeis University, Prescription Drug Monitoring Program Training and Technical Assistance Center
September 22–24, 2014
Washington, D.C.
The Weekly Update is a service provided by the SAMHSA Preventing Prescription Abuse in the Workplace Technical Assistance Center (PAW) to keep the field abreast of recent news and journal articles to assist in forming policy, research, and programs to reduce prescription drug misuse or abuse. Please note, the materials listed are not reflective of SAMHSA's or PAW's viewpoint or opinion and are not assessed for validity, reliability or quality. The Weekly Update should not be considered an endorsement of the findings. Readers are cautioned not to act on the results of single studies, but rather to seek bodies of evidence. Copyright considerations prevent PAW from providing full text of journal articles listed in the Weekly Update.